Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Büky

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapia Hungarica (English Edition)|January 1, 1976
The effect of the aminoketone nioben in essential circulatory hyperkinesisI Szám, P Büky
Orvosi Hetilap|February 3, 1980
[Aortic stenosis--angiodysplasia of the cecum]M Balázs, I Szám, P Büky
Orvosi Hetilap|September 19, 1971
[Hospitalization of influenza patients during epidemics]P Büky, L Jánossy, J Kaufmann
Orvosi Hetilap|December 8, 1974
[Amoebic liver abscess]P Büky, L Drexler, L Szücs
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1982
Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respirationI Szám, P Büky, A Gulyás, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapia Hungarica (English Edition)|January 1, 1976
The effect of the aminoketone nioben in essential circulatory hyperkinesisI Szám, P Büky
Orvosi Hetilap|February 3, 1980
[Aortic stenosis--angiodysplasia of the cecum]M Balázs, I Szám, P Büky
Orvosi Hetilap|September 19, 1971
[Hospitalization of influenza patients during epidemics]P Büky, L Jánossy, J Kaufmann
Orvosi Hetilap|December 8, 1974
[Amoebic liver abscess]P Büky, L Drexler, L Szücs
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1982
Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respirationI Szám, P Büky, A Gulyás, et al.
Pageof 1